The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 58 , ISSUE 3 ( July-September, 2016 ) > List of Articles


A Study to Evaluate the Effect of Body Mass Index on the Prevalence of Sleep-Disordered Breathing in Adult Patients with Metabolic Syndrome

Inderpaul Singh Sehgal, Sahajal Dhooria, Sunny Virdi, Ritesh Agarwal, Dhruva Chaudhry

Keywords : Obstructive sleep apnoea, Hypertension, Sleep disordered breathing Diabetes mellitus, Metabolic syndrome

Citation Information : Sehgal IS, Dhooria S, Virdi S, Agarwal R, Chaudhry D. A Study to Evaluate the Effect of Body Mass Index on the Prevalence of Sleep-Disordered Breathing in Adult Patients with Metabolic Syndrome. Indian J Chest Dis Allied Sci 2016; 58 (3):177-181.

DOI: 10.5005/ijcdas-58-3-177

License: CC BY-NC 4.0

Published Online: 17-11-2022

Copyright Statement:  Copyright © 2016; The Author(s).


Background: Obesity is a predisposing factor for obstructive sleep apnoea (OSA). Conversely, OSA increases the risk of developing hypertension and diabetes mellitus. Whether the presence of metabolic syndrome increases the risk of sleep-disordered breathing (SDB) independent of obesity remains unclear. Methods: Consecutive 25 non-obese and 25 obese adult patients with metabolic syndrome and Epworth Sleepiness Scale (ESS) score .10 underwent full night attended polysomnography. Baseline clinical and demographic parameters were recorded for all the patients. Obesity was defined as body mass index (BMI) .25kg/m2. Occurrence of SDB (central sleep apnoea and/or OSA), sleep efficiency, and time spent in each sleep stage were noted in both the study groups. Results: The study subjects were predominantly men (n=41, 82%) with a mean age of 47.1 years. A total of 38 (76%) subjects were diagnosed to have OSA. There was no difference in the prevalence of OSA between the study groups (non-obese versus obese, 20 [80%] versus 18 [72%]; p=0.508). Patients in both the groups had low median sleep efficiency (non-obese versus obese, 47% versus 48.7%; p=0.764), and an equal number of awakenings per hour of sleep (non-obese versus obese, median interquartile range [IQR], 21 [7.5-26.5] versus 18 [13-22.5]; p=0.763). None of the patients in either group had central sleep apnoea. Conclusion: Obstructive sleep apnoea is highly prevalent in patients with metabolic syndrome and excessive daytime sleepiness (ESS .10), and the prevalence of OSA in this population is independent of BMI.

PDF Share
  1. Budhiraja R, Budhiraja P, Quan SF. Sleep-disordered breathing and cardiovascular disorders. Respir Care 2010;55:1322–32.
  2. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med 1976;27:465–84.
  3. Strohl KP, Cherniack NS, Gothe B. Physiologic basis of therapy for sleep apnea. Am Rev Respir Dis 1986;134:791–802.
  4. Strohl KP, Redline S. Recognition of obstructive sleep apnea. Am J Respir Crit Care Med 1996;154:279–89.
  5. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Lancet 2005;366:1059–62.
  6. The IDF consensus worldwide definition of the metabolic syndrome. Available at URL: . Accessed on April 10, 2016.
  7. Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CE. “Syndrome Z”: the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 1998;53:S25–S28.
  8. Agrawal S, Sharma SK, Sreenivas V, Lakshmy R, Mishra HK. Stepped approach for prediction of syndrome Z in patients attending sleep clinic: a north Indian hospital-based study. Sleep Breath 2012;16:621–7.
  9. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230–5.
  10. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000;85:1151–8.
  11. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002;165:677–82.
  12. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleepdisordered breathing. JAMA 2000;284:3015–21.
  13. Newman AB, Foster G, Givelber R, Nieto FJ, Redline S, Young T. Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch Intern Med 2005;165:2408–13.
  14. Aurora RN, Casey KR, Kristo D, Auerbach S, Bista SR, Chowdhuri S, et al. Practice parameters for the surgical modifications of the upper airway for obstructive sleep apnea in adults. Sleep 2010;33:1408–13.
  15. Bhushan B, Misra A, Guleria R. Obstructive sleep apnea is independently associated with the metabolic syndrome in obese Asian Indians in northern India. Metab Syndr Relat Disord 2010;8:431–5.
  16. Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India 2009;57:163–70.
  17. Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea: The Epworth Sleepiness Scale. Chest 1993;103:30–36.
  18. Berry RB, Brooks R, Gamaldo CE, Harding SM, Marcus CL, Vaughn BV for the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.0., Darien, Illinois: American Academy of Sleep Medicine; 2012.
  19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.
  20. El-Sayed IH. Comparison of four sleep questionnaires for screening obstructive sleep apnea. Egyptian J Chest Dis Tuberc 2012;61:433–41.
  21. Silva GE, Vana KD, Goodwin JL, Sherrill DL, Quan SF. Identification of patients with sleep disordered breathing: comparing the four-variable screening tool, STOP, STOPBang, and Epworth Sleepiness Scales. J Clin Sleep Med 2011;7:467–72.
  22. Quan SF, Howard BV, Iber C, Kiley JP, Nieto FJ, O'Connor GT, et al. The Sleep Heart Health Study: design, rationale, and methods. Sleep 1997;20:1077–85.
  23. Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005;9:211–24.
  24. Vgontzas AN, Chrousos GP. Sleep-disordered breathing, sleepiness, and insulin resistance: is the latter a consequence, a pathogenetic factor, or both? Sleep Med 2002;3:389–91.
  25. Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014;2014:943162.
  26. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014;105:141–50.
  27. Krueger JM, Takahashi S, Kapas L, Bredow S, Roky R, Fang J, et al. Cytokines in sleep regulation. Adv Neuroimmunol 1995;5:171–88.
  28. Kapsimalis F, Richardson G, Opp MR, Kryger M. Cytokines and normal sleep. Curr Opin Pulm Med 2005;11:481–4.
  29. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997;82:1313–6.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.